Loading...
Loading...
Among the 8 tracked institutional investors we monitor, IKT (INHIBIKASE THERAPEUTICS INC) is held with a combined value of $29.76M across 16,707,361 shares. The largest holder is BlackRock, Inc. with a position worth $10.59M (0.00% of their portfolio). 3 funds opened new positions in the most recent quarter. 4 funds increased their holdings. 1 fund reduced its position.
Total Institutional Value
$29.76M
Total Shares Held
16,707,361
Institutional Holders
8
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | $10.59M | 0.00% | +90.7% |
| 2 | VANGUARD GROUP INC | $9.35M | 0.00% | New |
| 3 | MILLENNIUM MANAGEMENT LLC | $4.92M | 0.00% | +1623.9% |
| 4 | STATE STREET CORP | $2.83M | 0.00% | +203.8% |
| 5 | CITADEL ADVISORS LLC | $1.85M | 0.00% | -11.3% |
| 6 | FMR LLC | $120.90K | 0.00% | +25.4% |
| 7 | Point72 Asset Management, L.P. | $67.84K | 0.00% | New |
| 8 | RENAISSANCE TECHNOLOGIES LLC | $27.72K | 0.00% | New |
As of the latest SEC 13F filings, BlackRock, Inc. is the largest institutional holder of IKT with a position worth $10.59M, representing 0.00% of their portfolio. In total, 8 institutional investors hold IKT with a combined value of $29.76M.
In the most recent quarter, 3 funds opened a new position in IKT. Additionally, 4 increased their holdings and 1 reduced their positions.
Institutional investors hold $29.76M worth of IKT stock across 8 positions. The largest institutional holder is BlackRock, Inc. with $10.59M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For IKT, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their IKT positions.